Market Overview:
The global allergy rhinitis drug market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic rhinitis, increasing awareness about allergies and their treatment, and technological advancements in the field of allergy drugs. The global allergy rhinitis drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into tablet allergy rhinitis drugs and spray allergy rhinitis drugs. Tablet allergens are expected to dominate the global market during the forecast period owing to their high efficacy and easy availability.
Product Definition:
An allergy rhinitis drug is a medication that is used to treat symptoms of allergies, such as sneezing, itchy eyes, and a runny nose. These drugs work by blocking the effects of histamines, which are chemicals that are released by the body in response to an allergic reaction.
Tablet Allergy Rhinitis Drug:
Allergy rhinitis is a type of hay fever characterized by symptoms such as congestion, itching, and nasal obstruction caused due to an allergic response. The drug Allergy Rhinitis (AR) or tablet allergy rhinitis is the treatment of choice for this condition.
Spray Allergy Rhinitis Drug:
Spray Allergy Rhinitis (SAR) is a type of allergic rhinitis, which is characterized by symptoms such as itchy nose, sneezing, nasal congestion or discharge. SAR may occur due to various causes such as pollution (e.g., dust mites), insect bites & stings; food additives including preservatives and spices; latex; medications including antihistamines and decongestants; and others.
Application Insights:
Based on application, the global allergy rhinitis drug market is segmented into hospital, clinic or medical center and others. The hospital segment dominated the overall market in terms of revenue in 2017 due to a large patient base with allergic rhinitis symptoms that require immediate treatment. In addition, this segment has witnessed an increase in R&D initiatives by various manufacturers for developing new products specifically designed for patients with allergies and asthma.
The clinic or medical center application is expected to witness significant growth over the forecast period due to increasing awareness about allergies among consumers as well as healthcare professionals. Furthermore, growing consumer preference for non-prescription drugs owing to economic affordability coupled with accessibility are anticipated drive demand from this sector over the forecast period.
Other applications include pharmacies.
Regional Analysis:
Europe was the largest regional market in 2017 owing to high prevalence of tree nut allergy and increasing awareness about its treatment. In addition, growing number of product launches in this region is also expected to drive the market for allergen-specific drugs over the forecast period. Asia Pacific is anticipated to be one of the fastest-growing regions due to rising geriatric population, improving economic conditions and rapid urbanization & industrialization. Moreover, increasing disposable income levels are also projected to contribute toward growth during the forecast period.
Growth Factors:
- Increasing prevalence of allergic rhinitis
- Growing awareness about the benefits of allergen immunotherapy
- Rising demand for better treatment options for allergic rhinitis
- Technological advancements in diagnosis and treatment of allergic rhinitis 5. Growing number of clinical studies on allergen immunotherapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Allergy Rhinitis Drug Market Research Report
By Type
Tablet Allergy Rhinitis Drug, Spray Allergy Rhinitis Drug
By Application
Hospital, Clinic, Medical Center
By Companies
GlaxoSmithKline, Sanofi, ALK-Abello, Meda Pharmaceuticals, Teva Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Allergy Rhinitis Drug Market Report Segments:
The global Allergy Rhinitis Drug market is segmented on the basis of:
Types
Tablet Allergy Rhinitis Drug, Spray Allergy Rhinitis Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Medical Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Sanofi
- ALK-Abello
- Meda Pharmaceuticals
- Teva Pharmaceuticals
Highlights of The Allergy Rhinitis Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet Allergy Rhinitis Drug
- Spray Allergy Rhinitis Drug
- By Application:
- Hospital
- Clinic
- Medical Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allergy Rhinitis Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allergy rhinitis drug is a medication used to treat symptoms of allergies, such as sneezing, runny nose, and itchy eyes.
Some of the key players operating in the allergy rhinitis drug market are GlaxoSmithKline, Sanofi, ALK-Abello, Meda Pharmaceuticals, Teva Pharmaceuticals.
The allergy rhinitis drug market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allergy Rhinitis Drug Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Allergy Rhinitis Drug Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Allergy Rhinitis Drug Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Allergy Rhinitis Drug Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Allergy Rhinitis Drug Market Size & Forecast, 2020-2028 4.5.1 Allergy Rhinitis Drug Market Size and Y-o-Y Growth 4.5.2 Allergy Rhinitis Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablet Allergy Rhinitis Drug
5.2.2 Spray Allergy Rhinitis Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Medical Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allergy Rhinitis Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allergy Rhinitis Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablet Allergy Rhinitis Drug
9.6.2 Spray Allergy Rhinitis Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Medical Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablet Allergy Rhinitis Drug
10.6.2 Spray Allergy Rhinitis Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Medical Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablet Allergy Rhinitis Drug
11.6.2 Spray Allergy Rhinitis Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Medical Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablet Allergy Rhinitis Drug
12.6.2 Spray Allergy Rhinitis Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Medical Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablet Allergy Rhinitis Drug
13.6.2 Spray Allergy Rhinitis Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Medical Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allergy Rhinitis Drug Market: Competitive Dashboard
14.2 Global Allergy Rhinitis Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Sanofi
14.3.3 ALK-Abello
14.3.4 Meda Pharmaceuticals
14.3.5 Teva Pharmaceuticals